In fact, as a secreted protein, the clinical significance of OPG has been studied in several tumors including breast cancer, prostate cancer (PCa), multiple myeloma (MM), and hepatocellular carcinoma (HCC). Here, TNFRSF11B is linked to posterior cortical atrophy.